Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Kopran Limited ( (IN:KOPRAN) ) has issued an announcement.
Kopran Limited has announced the submission of a Draft Scheme of Amalgamation, which involves the merger of Kopran Laboratories Limited into Kopran Limited. This strategic move is expected to streamline operations and enhance the company’s market position, subject to necessary approvals from regulatory authorities and stakeholders.
More about Kopran Limited
Kopran Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is known for its range of formulations and active pharmaceutical ingredients, serving both domestic and international markets.
YTD Price Performance: -4.70%
Average Trading Volume: 26,830
Current Market Cap: 9.91B INR
See more insights into KOPRAN stock on TipRanks’ Stock Analysis page.